Abstract

Galactooligosaccharides (GOS) are an important class of dietary prebiotics that exert beneficial effects on intestinal microbiota and gut barrier function. In this study, high-purity GOS (HP-GOS) were investigated in vitro and in vivo and confirmed as prebiotic ingredients in rat diet. HP-GOS were successfully produced using a two-step process, enzymatic hydrolysis and fermentation by yeast. They were found to serve as a good substrate and carbon source for supporting the growth of probiotic bacteria more effectively than other commercial GOS. Following administration of 1% (by mass) of HP-GOS to rats, the growth of Bifidobacterium bifidum and B. longum in the gut increased most rapidly up to 12 h, and thereafter the increase was slow. Therefore, 1% HP-GOS was found to be acceptable for the growth of probiotic bacteria. Groups of animals that were orally administered HP-GOS and bifidobacteria during the study, and the group administered HP-GOS during the 2nd (days 13-15) and 4th (days 28-30) period of the study had significantly (p<0.05) higher numbers of bifidobacteria in faeces than groups receiving a single dose of bifidobacteria. HP-GOS affected the expression of genes encoding glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). There was a significant upregulation of GLP-1 and PYY mRNA with HP-GOS and bifidobacteria intake. We propose that the prebiotic properties of HP-GOS are potentially valuable for the production of functional foods for human consumption.

Highlights

  • There has been an increasing interest in the regulation of colonic microflora in order to improve the host’s health

  • high-purity GOS (HP-GOS) were successfully produced using a two-step process, enzymatic hydrolysis and fermentation by yeast. They were found to serve as a good substrate and carbon source for supporting the growth of probiotic bacteria more effectively than other commercial GOS

  • Monosaccharide mass fractions increased from 0.8 to 27.7 g per 100 g after the enzymatic reaction; these monosaccharides were completely removed by fermentation with S. cerevisiae, whereas lactose levels were slightly increased

Read more

Summary

Introduction

There has been an increasing interest in the regulation of colonic microflora in order to improve the host’s health. This has been achieved traditionally by dietary inclusion of live microbes as food supplements known as probiotics. Commercial GOS that contain complex mixtures of oligosaccharides with different glycosidic linkages and degrees of polymerization are usually synthesized by enzymatic transgalactosylation of lactose by β-galactosidases from various sources such as yeast, fungi or bacteria [3,4] These kinds of products can contain transgalactosylated oligosaccharides, unreacted lactose, glu-

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call